Symbol not found

NYSE:MYOV   00:00AM GMT
0.00
0.00 (0.00%)
Products

Myovant Sciences And Pfizer Receive U.S. FDA Approval Of Myfembree®

Published: 08/06/2022 01:00 GMT
Myovant Sciences Ltd (MYOV) - Myovant Sciences and Pfizer Receive U.S. FDA Approval of Myfembree®, a Once-daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis.
Myovant Sciences Ltd- Myovant and Pfizer Will Continue to Jointly Commercialize Myfembree, With Product Available Immediately.